Search

Author/Creator Peeters, R.P.

1. Balancing the benefits and harms of thyroid cancer surveillance in survivors of Childhood, adolescent and young adult cancer: Recommendations from the international Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium. (February 2018)

Authors:
Clement, S.C.; Kremer, L.C.M.; Verburg, F.A.; Simmons, J.H.; Goldfarb, M.; Peeters, R.P.; Alexander, E.K.; Bardi, E.; Brignardello, E.; Constine, L.S.; Dinauer, C.A.; Drozd, V.M.; Felicetti, F.; Frey, E.; Heinzel, A.; van den Heuvel-Eibrink, M.M.; Huang, S.A.; Links, T.P.; Lorenz, K.; Mulder, R.L.
Journal:
Cancer treatment reviews
Issue:
Volume 63(2018)
Page Start:
28
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Higher thyroid stimulating hormone leads to cardiovascular disease and an unfavorable lipid profile: EVidence from multi-cohort Mendelian randomization and metabolomic profiling. (August 2021)

Authors:
Van Vliet, N.A.; Bos, M.M.; Thesing, C.S.; Chaker, L.; Pietzner, M.; Houtman, E.; Neville, M.J.; Li-Gao, R.; Trompet, S.; Mustafa, R.; Ahmadizar, F.; Beekman, M.; Bot, M.; Budde, K.; Christodoulides, C.; Dehghan, A.; Delles, C.; Elliott, P.; Evangelou, M.; Gao, H.
Journal:
Atherosclerosis
Issue:
Volume 331(2021)
Page Start:
e40
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Intermediate and long-term adverse effects of radioiodine therapy for differentiated thyroid carcinoma – A systematic review. Issue 10 (December 2015)

Authors:
Clement, S.C.; Peeters, R.P.; Ronckers, C.M.; Links, T.P.; van den Heuvel-Eibrink, M.M.; Nieveen van Dijkum, E.J.M.; van Rijn, R.R.; van der Pal, H.J.H.; Neggers, S.J.; Kremer, L.C.M.; van Eck-Smit, B.L.F.; van Santen, H.M.
Journal:
Cancer treatment reviews
Issue:
Volume 41:Issue 10(2015)
Page Start:
925
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Is outcome of differentiated thyroid carcinoma influenced by tumor stage at diagnosis?. Issue 1 (January 2015)

Authors:
Clement, S.C.; Kremer, L.C.M.; Links, T.P.; Mulder, R.L.; Ronckers, C.M.; van Eck-Smit, B.L.F.; van Rijn, R.R.; van der Pal, H.J.H.; Tissing, W.J.E.; Janssens, G.O.; van den Heuvel-Eibrink, M.M.; Neggers, S.J.C.M.M.; van Dijkum, E.J.M. Nieveen; Peeters, R.P.; van Santen, H.M.
Journal:
Cancer treatment reviews
Issue:
Volume 41:Issue 1(2015)
Page Start:
9
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Thyroid hormone and its metabolites in relation to quality of life in patients treated for differentiated thyroid cancer. (13th June 2016)

Authors:
Massolt, E.T.; van der Windt, M.; Korevaar, T.I.M.; Kam, B.L.R.; Burger, J.W.; Franssen, G.J.H.; Lehmphul, I.; Köhrle, J.; Visser, W.E.; Peeters, R.P.
Journal:
Clinical endocrinology
Issue:
Volume 85:Number 5(2016)
Page Start:
781
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗